Nuwellis (NUWE) EBT Growth (3y) (2014 - 2026)
Nuwellis (NUWE) EBT Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | -2.47% |
| 2 | Stryker | 129.08 Bn | 126.21 Bn | 3.81 Bn | 7.77% |
| 3 | Medtronic | 108.57 Bn | 99.35 Bn | 6.41 Bn | 5.75% |
| 4 | Boston Scientific | 68.52 Bn | 67.07 Bn | 3.61 Bn | 37.81% |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn | 4.82% |
| 6 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | 61.06% |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.88 Bn | 1.98 Bn | -2.57% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.37 Bn | 21.25 Bn | 2.07 Bn | 32.11% |
| 10 | Nuwellis | 115,607.70 | -1.97 Mn | 1.68 Mn | 11.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.19% |
| Dec 31, 2025 | -7.90% |
| Sep 30, 2025 | 28.48% |
| Jun 30, 2025 | -43.08% |
| Mar 31, 2025 | 12.33% |
| Dec 31, 2024 | -27.98% |
| Sep 30, 2024 | 34.76% |
| Jun 30, 2024 | -17.77% |
| Mar 31, 2024 | 6.05% |
| Dec 31, 2023 | -21.06% |
| Sep 30, 2023 | 7.51% |
| Jun 30, 2023 | -7.30% |
| Mar 31, 2023 | -12.39% |
| Dec 31, 2022 | 24.35% |
| Sep 30, 2022 | 4.98% |
| Jun 30, 2022 | 1.10% |
| Mar 31, 2022 | 1.82% |
| Dec 31, 2021 | 77.44% |
| Sep 30, 2021 | -7.52% |
| Jun 30, 2021 | -4.20% |